NHANES 2017–2018 elastography data (n=4102) linked to mortality showed 59 deaths over ~24 months; decedents were older and more likely to have diabetes. MASLD (CAP ≥274 dB/m) with diabetes carried ...

Reliance on FIB-4 screening tool alone may not identify some patients with significant fib ...

Please provide your email address to receive an email when new articles are posted on . Hepatocellular carcinoma risk increased by 19% with every 5 kPa increase in liver stiffness measurement. Liver ...

Researchers in South Korea have developed an organoid disease model and non-destructive stiffness analysis technology for evaluating the efficacy of new drugs for fatty liver disease. The research ...

Liver stiffness and severe fibrosis, as measured by FibroScan, are independently linked to type 2 diabetes (T2DM) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), new ...

Spleen stiffness measurement (SSM) offers a noninvasive method to diagnose portal hypertension in BCR::ABL1-negative MPN patients, potentially improving patient management. SSM captures hepatic ...

Researchers in South Korea have developed an organoid disease model and non-destructive stiffness analysis technology for evaluating the efficacy of new drugs for fatty liver disease. The research ...

Portal hypertension (PHT) is a severe complication of chronic liver disease, like cirrhosis, where increased pressure builds up in the portal vein. This major blood vessel drains blood from the ...

Waist circumference is the strongest predictor of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progression to steatohepatitis and liver stiffness in both the general adult ...